Omnicell Shares Jump on Strong Q2 Print but Slide After Guidance Disappoints
Omnicell rallied intraday after reporting Q2 adjusted EPS of $0.94 and revenue of $312.21 million, both ahead of analyst estimates, but the stock pared gains following guidance for Q3 and full-year revenue that fell short of consensus. The mixed release highlights near-term uncertainty about the pace of recovery and the rollout of the Titan XT cabi…